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Abstract
 
The quantitative adaptation of receptor thresholds allows cells to tailor their responses to
changes in ambient ligand concentration in many biological systems. Such a cell-intrinsic cali-
bration of T cell receptor (TCR) sensitivity could be involved in regulating responses to
autoantigens, but this has never been demonstrated for peripheral T cells. We examined the
ability of monoclonal naive T cells to modulate their responsiveness differentially after exposure
to fourfold different levels of persistent antigen stimulation in vivo. T cells expanded and entered
a tolerant state with different kinetics in response to the two levels of stimulation, but eventually
adjusted to a similar slow rate of turnover. In vivo restimulation revealed a greater impairment
in the proliferative ability of T cells resident in a higher antigen presentation environment. We
also observed subtle differences in TCR signaling and in vitro cytokine production consistent
with differential adaptation. Unexpectedly, the system failed to similarly compensate to the
persistent stimulus in vivo at the level of CD69 expression and actin polymerization. This
greater responsiveness of T cells residing in a host with a lower level of antigen presentation
allows us to demonstrate for the first time an intrinsic tuning process in mature T lymphocytes,
albeit one more complex than current theories predict.
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Introduction
 
Cellular adaptation to environmental stimuli regulates a variety
of biological responses ranging from chemotaxis in bacteria
to visual perception in the eye. Many receptor systems capable
of adapting their responsiveness are concerned with rapid
changes in the concentration of extracellular ligand and use
the steady state levels to generate appropriate negative feed-
back that effectively shuts down signal transduction in the
absence of a change. The delay in the generation of such
feedback also extends the duration of the response, thereby
allowing the flexible design of cellular response states over a
broad range of ligand concentrations.
In the innate immune system, quantitative receptor
adaptation  regulates neutrophil chemotaxis (1), macro-
phage activation by endotoxin (2), and possibly the recogni-
tion of self-MHC by NK cells (3). Developing T cells in
the thymus undergo changes in the kinds of molecules
mobilized to the TCR signaling machinery (4) and in the
expression of coreceptors like CD5 (5) that allow the mature
cells to show reduced responsiveness to a similar stimulus in
the periphery (6). These changes effect a “tuning” of the
TCR, ostensibly toward positively selecting ligands in the
thymus, and help set the activation threshold for naive
TCRs in the periphery (7–9) such that T cells in the periphery
should only make a response if the level of antigenic stimulus
exceeds this activation threshold.
The potential for individual mature T cells to modulate
their activation thresholds in dynamic conversation with
ambient antigenic stimulation is predicted by the tunable
activation threshold (TAT) model of Grossman and Paul
(10, 11). In this model, naive T cells maintain tolerance to
self-MHC–peptide complexes by tuning their TCR signal-
ing to match the persistent stimulus. A rapid change in the
strength of stimulus initiates a response in these T cells but
persistence of the new level of stimulus allows them to readjust
their activation thresholds accordingly. The existence of
such cell-intrinsic tunability of activation thresholds in indi-
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vidual mature T cells has not yet been demonstrated experi-
mentally. It has, in contrast, recently been reported that na-
ive T cells removed from the presence of self-MHC
interactions in vivo show a rapid loss of responsiveness (12).
Peripheral T cells exposed to tolerogenic forms of solu-
ble or persistent self-antigen enter a state of unresponsive-
ness that significantly reduces their ability to make cyto-
kines or proliferate (13–15). This state, called adaptive
tolerance, is also accompanied by reduced transduction of
various TCR-mediated signals (16). Furthermore, in con-
trast to T cells rendered clonally anergic (17), both mono-
clonal (18) and polyclonal (19) T cells adaptively tolerant to
persistent self-antigens in vivo are able to recover respon-
siveness upon removal of the antigenic stimulus. The dem-
onstration of such reversible states suggests that peripheral
T cells can dynamically move between at least two ex-
tremes of responsiveness (on or off) depending on the pres-
ence or absence of persistent stimulation.
Application of the TAT model to the phenomenon of
adaptive tolerance phenomena allows for a mechanism by
which mature peripheral T cells could continue to assess
their potential for autoreactivity and subsequently alter
their responsiveness using continuous feedback from the
environment. Self-reactive T cells could thereby down-
modulate potentially autoimmune responses and yet con-
tinue to maintain a diverse repertoire capable of responding
to a stronger stimulus from dangerous pathogens. Although
there is some evidence that polyclonal repertoires of T cells
may undergo selection for affinity during the course of an
immune response (20, 21), affinity maturation by selection
for individual clonotypes in a population with divergent
TCRs does not address the possibility that activation
thresholds might also be tuned at the level of individual T
cells. Neither can this be addressed by studies using TCR
transgenic populations from mice capable of endogenous
TCR rearrangements, because of the high probability of
expressing dual receptors. Therefore, the ability of mono-
clonal T cells to dynamically exist in multiple states of re-
sponsiveness coordinate with the level of ambient stimulus
is yet to be demonstrated. The existence of such a cell-
intrinsic adaptation process is a critical prediction of the
Grossman and Paul model.
We adoptively transferred a monoclonal population of
naive TCR transgenic T cells into two recipient mice pre-
senting different persistent levels of the cognate antigen to
ask if T cell tolerance in vivo demonstrates intrinsic adapta-
tion to different ambient levels of stimulation. Consistent
with the predictions of the TAT model, adaptively toler-
ized T cells resident in an environment with a higher level
of antigen presentation showed a lower level of prolifera-
tion, cytokine production, and TCR signaling compared
with similar T cells resident in an environment with a
lower level of antigen presentation. Interestingly, T cell ad-
aptation to the lower stimulus was kinetically slower and
also less stable. Furthermore, the tuning was not a simple
recruitment of negative feedback to prevent all responses to
the stimulus, rather, it was manifested by the control of
post-expansion turnover in vivo. Other markers of in vivo
 
activation such as CD69 expression and actin polymeriza-
tion were not compensated to equal levels, but in fact dis-
played greater responsiveness to the ambient stimulus of the
low environment. These observations demonstrate that
mature peripheral CD4
 
  
 
T cells undergo cell-intrinsic ad-
aptation in response to persistent antigenic stimulation, al-
beit in a manner more complex than predicted by current
theoretical models.
 
Materials and Methods
 
Mice.
 
All mice were backcrossed onto the B10.A/SgSnAi
background and bred at the NIAID contract facility at Taconic
Farms, an American Association for Accreditation of Laboratory
Animal Care–accredited specific pathogen-free barrier. The
pigeon cytochrome c (PCC) 81–104-specific 5C.C7 TCR
transgenic RAG2
 
 
 
/
 
  
 
mouse as well as B10.A,CD3
 
 
 
 
 
/
 
 
 
, and
mPCC(RO),CD3
 
 
 
 
 
/
 
  
 
mice have been described (18). The ePCC
(SPK) transgenic created by Oehen et al. (22) expresses PCC un-
der the control of the MHC-I promoter and Ig enhancer elements
identical to the mPCC transgene. However, this construct lacks
the neuraminidase membrane-targeting domain and therefore tar-
gets to the mitochondria. We bred the BALB/c,ePCC mouse
(Jackson ImmunoResearch Laboratories) onto the B10.A,CD3
 
 
 
 
 
/
 
 
 
background and used them at N5 for our experiments.
B10.BR,3A9
 
 
 
/
 
  
 
TCR transgenic mice were generated by Ho et
al. (23) and provided by I. Gery (National Eye Institute of the
NIH, Bethesda, MD).
 
T Cell Isolation, 5,6-Carboxy-Fluorescein Succinimidyl Ester
(CFSE) Labeling, and Adoptive Transfer.
 
Naive T cells used for
adoptive transfer were obtained by pooling the cervical, axillary,
brachial, inguinal, mesenteric, periaortic, and pancreatic lymph
nodes of B10.A,5C.C7(Tg) RAG2
 
 
 
/
 
  
 
mice. Typically this yields
90–93% CD4
 
  
 
T cells and no further purification was performed.
3–5 
 
  
 
10
 
6 
 
cells were injected i.v. into recipient mice. For tracking
in vivo division, cells were labeled with 2 
 
 
 
M CFSE (Molecular
Probes) in PBS plus 0.5% FCS at 37
 
 
 
C for 15 min. Single cell sus-
pensions from lymph nodes and spleens of recipients were stained
with anti–V
 
 
 
3-PE (KJ25; BD Biosciences) and anti–CD4-TC
(Caltag) to enumerate the percentage of T cells. T cells were de-
pleted of recipient origin cells by two rounds of negative selection
with dynabeads (Dynal) and antibodies to B220 (RA3-6B2),
CD11b (M1/70), I-E
 
k 
 
(17.3.3S), and CD8 (53-6.7; BD Bio-
sciences). T cells for retransfer were derived from recipient mice
that received unlabeled naive T cells and were labeled with CFSE
as described above after the enrichment process. Surface expression
of CD69 (H1.2F3), CD25 (PC61), CD5 (53-7.3), or CD44 (IM7)
was examined with PE-labeled antibodies (BD Biosciences).
For intracellular F-actin staining, 1–2 
 
  
 
10
 
6 
 
freshly isolated
cells from recipients were stained for surface TCR/CD4 before
fixing and permeabilization using the Fix-Perm kit (Caltag) ac-
cording to the manufacturer’s instructions. Alexa 546–coupled
phalloidin (Molecular Probes) was used to stain processed cells for
30 min on ice.
 
In Vitro T Cell Proliferation Assays and Cytokine Measurement.
 
In vitro responsiveness of T cells to HPLC-purified PCC 81–104
peptide (Bachem) was routinely assayed using 10
 
4 
 
T cells cocul-
tured with half-log dilutions of the peptide and 5 
 
  
 
10
 
5 
 
irradiated
(3,000 rads) B10.A splenocytes in a 1:1 mix of RPMI 1640 and
EHAA (Biofluids Inc.) plus 10% FCS, 4 mM glutamine, 200 
 
 
 
g/
ml penicillin, 200 
 
 
 
g/ml streptomycin, 25 
 
 
 
g/ml gentamicin,
and 50 
 
 
 
M 2-ME. For anti-CD3 responses, 96-well flat-bottomT
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polystyrene plates (Corning Inc.) were coated with 2C11 (BD
Biosciences) in carbonate buffer, pH 9.5, for 4 h at 37
 
 
 
C or over-
night at 4
 
 
 
C. Plates were washed with culture medium and dried
briefly before seeding with 10
 
4 
 
T cells and anti-CD28 ascites (di-
luted 1:5,000).
After 48 h, 100 
 
 
 
l of the supernatant was removed for measur-
ing secreted cytokines and remaining cells were cultured for an
additional 20–24 h with 1 
 
 
 
Ci per well of tritiated thymidine
(Amersham Biosciences). Cells were harvested using a Brandel
96-well harvester and incorporated tritium was counted using a
Wallac Trilux 1450 scintillation counter. All cytokine measure-
ments used the Quantikine M kits (R&D Systems) according to
the manufacturer’s instructions.
For quantitating APC function in vitro, splenocytes were used
as mixed populations or subsetted by sorting at the NIAID flow
facility (to 
 
 
 
98% purity) and inactivated by 3,000 rads irradiation
(non–B cells) or 50 
 
 
 
g/ml Mitomycin C (B cell fractions).
A population of in vitro–generated preactivated T cells was
used as a sensitive tester population to measure the antigen pre-
sentation by ex vivo–isolated mPCC and ePCC spleen cells.
These cells were generated by stimulating 5C.C7,RAG2
 
 
 
/
 
  
 
lym-
phocytes with 1 
 
 
 
M PCC and irradiated B10.A splenocytes for
3–4 d. The stimulated T cells were harvested and separated from
dead cells by layering on Lympholyte M (Accurate Chem). Live
cells were “rested” by culturing in complete medium supple-
mented with 10 units/ml IL-2 for at least 7 d. Similar hen egg
lysozyme (HEL)-specific 3A9 T cells were generated by two
rounds of amplification with 1 
 
 
 
g/ml HEL presented first by
B10.BR and subsequently by B10.A splenocytes.
 
Analysis of In Vivo Proliferation by CFSE Staining.
 
Dilution of
CFSE was quantitated as previously described (24). Areas under
histogram peaks calculated using BD CELLQuest™ software was
used to enumerate the number of cells in each division (i) at each
time point. This number was divided by 2
 
i 
 
to derive numbers of
input cells contributing to the peak. Total summation of such co-
horts was used to normalize each peak as a percentage and fitted
to a Gaussian distribution. The mean of that distribution was esti-
mated and used as the mean number of divisions (
 
n
 
) of the popu-
lation at that time. Values of 
 
n
 
 at multiple time points (t) were fit-
ted to a linear regression and the rate of division (slope) and lag
time were (value of t at 
 
n 
 
  
 
1) derived. This form of analysis was
robust when applied to naive T cells (R
 
2 
 
  
 
0.95–0.99 in the
Gaussian fit), whereas antigen-experienced T cells showed signif-
icant variability between experiments (R
 
2 
 
  
 
0.48–0.99). Part of
this was due to the heterogeneity in the size and labeling of the
antigen-experienced population.
 
BrdUrd Incorporation In Vivo.
 
Turnover in vivo was measured
by injecting 0.8 mg BrdUrd (Sigma-Aldrich) in PBS i.p. once
every 12 or 24 h. Intracellular staining for BrdUrd used the
BrDU Flow kit (BD Biosciences) according to the manufac-
turer’s instructions.
 
Phosphorylation of ERK.
 
1–2 
 
  
 
10
 
6 
 
purified T cells were
stimulated on 24-well plates coated with 10 
 
 
 
g/ml anti-CD3 in
PBS at 37
 
 
 
C. T cells (in 50 
 
 
 
l volume) were stimulated for 1–15
min and the plate was quick frozen by floating on liquid nitrogen.
Cell lysates were freeze thawed in 2X SDS sample buffer (Bio-
Rad Laboratories) supplemented with 1 
 
 
 
M 2-ME and 10 
 
 
 
M
Na
 
2
 
VaO (Fisher Scientific). Lysates were boiled for 10 min, soni-
cated, and 45 
 
 
 
l were separated on an 8–16% SDS-PAGE gel
(Bio-Rad Laboratories) for transfer to PVDF membranes (Hy-
bond; Amersham Biosciences). Membranes were blocked with
5% Blotto (Santa Cruz Biotechnology, Inc.) and probed with
anti-phospho ERK mAb (Cell Signaling or Santa Cruz Biotech-
nology, Inc.), followed by biotinylated anti–mouse antibody
(Santa Cruz Biotechnology, Inc.) and Avidin-Biotin AP (Vector
Laboratories). The bound AP was detected using the ECF reagent
(Amersham Biosciences). Blots were stripped of the bound anti-
body and reprobed with anti-ERK (Upstate Biotechnology) and
biotinylated anti–rabbit IgG (Santa Cruz Biotechnology, Inc.).
The amount of pERK signal was detected on a Molecular Dy-
namics PhosphorImager and is expressed as a percentage of the
total ERK signal from the same lane.
 
Online Supplemental Material.
 
T cells adapted to PCC-lo or
PCC-hi levels of antigen presentation were recovered 34 d after
the transfer, purified, and stimulated with plate-bound anti-CD3
and soluble anti-CD28. The amount of IL-4 (Fig. S1 a), IL-10
(Fig. S1 b), and TNF 
 
  
 
(Fig. S1 c) secreted is shown in Fig. S1.
The expression of activation markers CD25 (Fig. S2 a), CD44
(Fig. S2 b), or CD5 (Fig. S2 d) and the levels of the TCR (Fig. S2
c) on the T cell resident in the PCC-hi or PCC-lo environments
Figure 1. In vitro antigen presentation by mPCC
splenocytes is greater than that by ePCC splenocytes.
(a) Functional presentation of the transgene-derived
antigen by mPCC,CD3  /  ( ) and ePCC,CD3e / 
( ) APCs to T cells in vitro was quantitated by com-
paring the proliferation of PCC-specific tester T cells
to fresh splenocytes from either transgenic or antigen-
deficient CD3  /  ( ) mice. Tester T cells used were
from a rested, in vitro–preactivated population of
5C.C7 T cells, which are extremely sensitive to relatively
subtle variations in antigen presentation. Dotted lines
from the y axis denote basal proliferation elicited by
each type of APC estimated from a curve fit of the
data. (b) Proliferation of 3A9 T cells to HEL presented
by splenocytes as in (a) shows that the presentation dif-
ferences are specific to PCC. (c) Presentation of antigen
by the two transgenics is not differentially compart-
mentalized in splenic APCs. Sorted CD11c  B220 ,
CD11c  B220 , or B220  cells freshly isolated from
the mPCC,CD3  /   (solid bars), ePCC,CD3  / 
(hatched bars), or CD3  /  mice (open bars) were
used to stimulate tester T cells in vitro.T
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for different periods of time (after adoptive transfer) is shown in
Fig. S2. Figs. S1 and S2 are available at http://www.jem.org/cgi/
content/full/jem.20030913/DC1.
 
Results
 
Differential In Vitro Presentation of PCC by Splenocytes from
mPCC and ePCC Transgenic Mice.
 
To generate host envi-
ronments expressing different amounts of the same “self”-
antigen, we introduced the homozygous CD3
 
 
 
 
 
/
 
  
 
muta-
tion into two PCC transgenic mice (mPCC and ePCC)
originally created by Oehen et al. (22). Quantitation by
Northern hybridization revealed that splenocytes from the
CD3
 
 
 
 
 
/
 
  
 
mice homozygous for the ePCC transgene ex-
pressed fivefold lower levels of the antigen transcript than
those homozygous for mPCC (unpublished data), confirm-
ing earlier observations in T cell–sufficient hosts (22). For
the purposes of this study it was critical to test if the differ-
ences in message levels were also reflected in differential
presentation of processed antigen to T cells by APCs. We
assayed this by using freshly isolated splenocytes from each
host to stimulate a population of previously activated PCC-
specific tester T cells, generated as described in Materials
and Methods (Fig. 1 a). In the absence of added PCC pep-
tide, the mPCC,CD3
 
 
 
 
 
/
 
  
 
splenocytes elicited 
 
 
 
63% of
maximal tester cell proliferation. In contrast, the ePCC,
CD3
 
 
 
 
 
/
 
  
 
splenocytes elicited only 28%. The intersection
of these basal proliferation values on the antigen-induced
proliferative dose response curve obtained with CD3
 
 
 
 
 
/
 
 
 
splenocytes not expressing PCC (Fig. 1 a, horizontal lines),
shows that presentation by mPCC,CD3
 
 
 
 
 
/
 
  
 
splenocytes is
equivalent to a fourfold (average difference of 4.1-fold, 
 
n 
 
 
 
4) increase in antigen concentration over that presented by
ePCC,CD3
 
 
 
 
 
/
 
  
 
splenocytes.
 
Fractionation of the splenocytes from the two hosts into
CD11c
 
  
 
B220
 
  
 
(dendritic cells), CD11c
 
  
 
B220
 
  
 
(macro-
phages), or B220
 
  
 
(B cells) by FACS
 
® 
 
sorting to 
 
 
 
98% pu-
rity, did not reveal any differential compartmentation of
the antigen in the two hosts (Fig. 1 c). We also ruled out
the possibility that the antigen in these two mice was ex-
pressed differentially in other tissue locations by using ly-
sates from multiple tissues as a source of antigen to stimu-
late previously activated T cells in vitro. Only lysates from
spleen and lymph nodes resulted in significant stimulation
and in both cases mPCC,CD3
 
 
 
 
 
/
 
  
 
tissues yielded more
stimulation than ePCC,CD3
 
 
 
 
 
/
 
  
 
tissues (unpublished data).
Finally, APCs from the two mice did not show a similar
difference in their ability to stimulate an HEL-specific cell
line derived from 3A9 TCR transgenic mice (Fig. 1 b), ar-
guing for antigen specificity in the differential presentation.
Therefore, we refer to the mPCC,CD3
 
 
 
 
 
/
 
  
 
mice as
PCC-hi and the ePCC,CD3
 
 
 
 
 
/  mice as PCC-lo recipi-
ents for the rest of this report.
In Vivo Proliferation of Monoclonal T Cells to Different Levels
of Persistent Antigen Stimulation. A monoclonal popula-
tion of  92% pure naive CD4  T cells specific for the
PCC 81–104 peptide, isolated from the lymph nodes of
B10.A,5C.C7,RAG2 /  TCR transgenic mice, was i.v.
injected into the PCC-hi or PCC-lo antigen transgenic
hosts. Within 2 h after adoptive transfer, 10–20% of the
injected 5C.C7 T cells populate the nodes and spleen of
either the PCC-hi or PCC-lo hosts. This number was
similar in the two recipients and did not significantly in-
crease over the next 24 h. T cells in either host started
proliferating in vivo between days 1 and 2 after transfer
(Fig. 2 a). The initial burst of expansion to the PCC-hi
stimulus resulted in a 30–70-fold increase in recovery of T
Figure 2. Naive T cells expand differentially in the
two environments but eventually achieve similar turnover
rates. (a) Naive 5C.C7,RAG2 /  T cells transferred
into the PCC-hi ( ) or PCC-lo ( ) recipients were
recovered after various days. The absolute number of
recovered T cells on each day was normalized to that
on day 1 in each group. Three experiments are averaged
on days 1–5 and for subsequent time points showing
error bars. (b and c) Different levels of persistent antigen
induce T cell cycling with the same lag time, but affect
the subsequent rate of proliferation. Dilution of CFSE
in the T cells recovered from PCC-hi or PCC-lo hosts
was analyzed using the Gett-Hodgkins method to cal-
culate the cell division profile over the first 68 h. Overlay
of dotted lines in (c) represents the raw data fitted to
an exponential rise to the max function. The best fit
parameters (R2     0.97–0.99) for the PCC-hi and
PCC-lo data are y0    11.9   3.3 and  12.2   5.2,
a   19.8   2.5 and 17.5   4.7, and b   0.966  
0.008 and 0.957   0.011, respectively. (d and e) Prolif-
erative expansion is contained earlier in the higher
stimulus environment, but is eventually modulated to
similar extents in the two hosts. (d) BrdUrd incorporation
in the PCC-hi (red lines) or PCC-lo (blue lines) resident
T cells was measured after daily injections of BrdUrd
between days 7 to 11 (A) or 32 to 36 (B). Green lines
represent negative controls. (e) Incremental BrdUrd
incorporation over the 5 d of labeling from days 32 to 36.T
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cells by the third day. Subsequently, the rate of net expan-
sion slowed down, yielding one more population dou-
bling by day 4 and accounting for a 75–150-fold total ex-
pansion of the transferred T cells. As previously reported
(18), the expansion phase in the PCC-hi host is followed
by a small decline in recovery (between days 4 and 7) and
a subsequent steady state in which the population size in-
creases only marginally out to 150 d. The initial expansion
in the PCC-lo host was similar to that in the PCC-hi en-
vironment. By the third day after transfer, however, it was
significantly slower and reached a peak of only 30–50-fold
by day 4. Consistent with this reduced proliferative burst,
the subsequent steady state T cell recoveries from the
PCC-lo recipients were consistently two- to fourfold
lower than the PCC-hi host (mean of 2.82-fold; n   20;
P   0.0001). This lower plateau occurs despite the fact
that the T cells do not go through a significant decline be-
tween days 4 and 12 in the PCC-lo host. However, at
very late time points (beyond 70 d), there appears to be a
sizeable loss of cells in the PCC-lo host (unpublished
data). Similar transfers into antigen-deficient, T-deficient
environments did not induce proliferation for up to 6 d
and the subsequent slow “lymphopenia-driven” prolifera-
tion resulted in only a four- to fivefold net expansion as
late as 2 mo after transfer (18).
To better quantitate the initial rate of expansion of the
naive 5C.C7 T cells in the two transgenic hosts, we ana-
lyzed the dilution of the CFSE dye in T cells recovered at
4–6-h intervals between 24 and 72 h after adoptive transfer
(Fig. 2 b). The mean division number was calculated and
plotted against the time of recovery (Fig. 2 c). This form of
analysis allowed us to mathematically model the initiation
of cycling and the subsequent rate of division of the trans-
ferred T cells. The theoretically estimated lag time for entry
into division was the same in both the PCC-hi and PCC-
lo hosts. After entry into cycle, the analysis revealed an ex-
tremely rapid period of division in both hosts (Fig. 2, b and
c). In the PCC-hi host, the mean doubling time was 5.9 h
between 30 and 52 h. This initial pace was slightly faster
than in the PCC-lo host, where the mean doubling time
was 7.2 h. For three separate experiments the average mean
doubling time in the PCC-lo host (5.8 h) was 25% longer
than in the PCC-hi host (4.7 h). This is consistent with the
observed decrease in net expansion in the PCC-lo host by
approximately one division at the end of 48 h. After 52–56 h,
the T cells in both hosts lose their initial momentum and
divide more slowly. A second linear fit of the data gener-
ated in the PCC-lo host from 56–72 h revealed that the T
cells now divided once every 21.7 h (mean of two experi-
ments) compared with 15.1 h in the PCC-hi host. This
43% increase in the doubling time in the PCC-lo host re-
duced the mean expansion at 72 h by approximately two
divisions relative to the PCC-hi host. The proliferative be-
havior of the T cells at all of the time points through 68 h
could also be modeled as an exponential rise to the max
function [y   y0   a (1   bx)] (Fig. 2 c, dotted lines). This
mathematical analysis predicts that in contrast to reports
concerning in vitro T cell proliferation (24, 25), the
strength of persistent antigenic stimulus in vivo regulates
the rate of cell cycle progression and not the time to first
division. We further confirmed this observation by analyz-
ing the percentage of naive T cells recruited to division at
shorter intervals from 28 to 38 h. Analysis of seven such
time points revealed no significant difference between T
cells in the hi and lo hosts (mean ratio of 1.02; P   0.16).
We were also able to estimate the loss of cells during the
expansion phase by calculating the theoretical expansion of
T cells from the CFSE profiles and comparing the actual
numbers recovered at 72 h. Over three experiments, we
could account for 78   9% of the T cells in the PCC-hi and
82   11% of the cells in the PCC-lo hosts, suggesting that
there was minimal effect of cell death or migration in either
host during the expansion phase between days 1–3 in vivo.
The in vivo turnover of cells after day 3 could not be re-
liably assayed by CFSE analysis due to poor resolution of
the peaks after seven to eight divisions. Therefore, we eval-
uated the turnover by BrdUrd labeling (Fig. 2, d and e).
Daily injections of BrdUrd between days 7 and 11 (5 d) in
the PCC-hi host resulted in incorporation by 56% of the T
cells. This level was substantially greater (79%) in the PCC-
lo host (Fig. 2 d, A). Thus, although the initial rate of ex-
pansion was more rapid in the PCC-hi host, the turnover
was also contained more rapidly in this environment, re-
sulting in a transient reversal of the rate of proliferation in
the two hosts. 32 d after transfer, however, a 5-d labeling
(with twice daily injections of BrdUrd) resulted in compa-
rable in vivo incorporation in the two T cell populations
(31.2% in the PCC-hi host and 33.2% in the PCC-lo host;
Fig. 2 d, B). 18 independent comparisons of BrdUrd incor-
poration over various labeling durations between days 22
to 76 yielded a mean PCC-lo/PCC-hi ratio of 1.02 ( / 
1.15). Finally, quantitation of the daily BrdUrd incorpora-
tion during the 5-d labeling between days 32 and 36 (Fig. 2
e) revealed a least squared fit slope of  5% of the cells di-
viding every day in both hosts. Therefore, after the initial
phase of rapid expansion was contained, the turnover of T
cells in either environment was constrained to similar rates,
consistent with adaptation of the T cells to the same level
of proliferative responsiveness, despite persistent differences
in the level of antigen presentation.
Differential Proliferative Responsiveness of PCC-hi– and
PCC-lo–adapted T Cells In Vivo. The restriction of in
vivo proliferation in both hosts is consistent with an adap-
tive process but could also be influenced by T cell density
and other environmental influences. To compare the in-
trinsic in vivo proliferative potential of the two T cell pop-
ulations, we retransferred 2–3   106 purified T cells into
fresh PCC-hi hosts. As previously reported (18), PCC-hi–
adapted T cells proliferated more slowly than naive T cells
to this fresh challenge (Fig. 3 a), reaching a peak expansion
of 5–8   106 cells (compared with 40–60   106 for naive T
cells) by 4 d. Interestingly, as early as day 2, T cells recov-
ered from the PCC-lo host seemed to expand faster than
the PCC-hi–experienced T cells. Over the next 3 d, PCC-
lo–experienced T cells expanded to a two- to threefold
higher level (10–19   106 cells) than the PCC-hi–adaptedT
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T cells, yet significantly lower than naive T cells. The dif-
ference in expansion resulted in a 2.09  /  1.27-fold (n  
4; P   0.006) higher plateau level for the PCC-lo–adapted
T cells compared with the PCC-hi–adapted cells.
The differences in the proliferation of these adapted T
cells was quantitated by following the dilution of CFSE in
the dividing cells at short intervals of time between 24 and
72 h (Fig. 3 b). In an analysis of the CFSE peaks by the
Gett-Hodgkins method (Fig. 3 c), naive T cells expanded
initially with a doubling rate of 4.5 h (R2   0.99). The
PCC-lo–adapted T cells had an average doubling time of
24.5 h (R2   0.85). Most of the T cells in the PCC-hi–
adapted population did not divide in this early time inter-
val, making it difficult to accurately determine the dou-
bling time for this cohort. Therefore, we supplemented
this form of analysis with a quantitation of the disappear-
ance of the undivided CFSE peak over the first 84 h (Fig.
3 d). In this analysis, naive T cells divided very rapidly be-
tween 30 and 48 h, exiting the undivided pool at a rate of
5   0.5% per hour (estimated from the slope of the linear
regression overlay in Fig. 3 d). All the input cells had di-
vided at least once by 45 h. In contrast, both tolerant pop-
ulations displayed a biphasic decay pattern. In the first lin-
ear phase (dotted lines mark the two linear phases of the
decay in Fig. 3 d), 35% of the PCC-hi–adapted T cells di-
vided out of the input population at the rate of 1.2  
0.1% per hour. This initially dividing cohort was signifi-
cantly larger (69%) in the PCC-lo–adapted T cells and
their rate of entry into cycle was 2.4-fold faster (at 2.9  
0.6% per hour). Subsequently, a second phase of division
was evident in both tolerant populations, but again the
PCC-hi–adapted T cells proceeded at a slower rate (0.4%
per hour) than the PCC-lo–adapted T cells (1.3% per
hour). Complete removal of the undivided population
took  84–96 h for the PCC-lo–adapted T cells, whereas
even at this time, undivided T cells were still evident in
the PCC-hi–adapted cells. Thus, although both the adap-
tively tolerized populations display a complex mixture of
proliferative behaviors, each component reveals about a
threefold difference in responsiveness between the two
experimental groups when confronted with an identical in
vivo challenge. Such a gradation in the in vivo prolifera-
tive behavior is consistent with the existence of different
thresholds for responding to a strong antigenic challenge
by CD4  T cells adapted to different levels of persistent
antigen presentation.
Strength of Stimulation Influences the Kinetics and Extent of
Adaptive Tolerance. Adaptive tolerance in vivo does not
result in a complete loss of in vitro T cell proliferation, but
significantly reduces the ability of the cells to secrete a vari-
ety of cytokines in vitro (18). We compared this phenotype
in T cells resident for various periods of time in either the
PCC-lo or PCC-hi recipient. T cells were purified away
from the host cells by negative selection (yielding a T cell
population of between 70 to 90% purity) and stimulated in
vitro with titrations of PCC 81–104 peptide on irradiated
Figure 3. The quantitative impairment of in vivo
responsiveness varies with the level of persistent antigen
presentation experienced. (a) 5C.C7,RAG2 /  TCR
transgenic cells resident for 22–28 d in the PCC-hi
host ( ) proliferate poorer than those resident in the
PCC-lo host ( ) upon retransfer into a fresh PCC-hi
environment. Both the adapted T cells are desensitized
relative to naive T cells ( ) establishing a hierarchy of
adaptations in vivo. Data are averaged over three separate
experiments. (b) The expansion of adapted T cells was
monitored by CFSE dilution over short intervals of
time after transfer of 28-d PCC-hi–adapted (P-hi),
PCC-lo–adapted (P-lo), or naive (Nv) T cells into
fresh PCC-hi mice. Numbers on the left represent the
time points sampled in hours. (c) Quantitative analysis
of the CFSE profiles in (b) by the Gett-Hodgkins
method. (d) Initiation of cell cycling in the transferred
T cells quantitated by the disappearance of the zero
division CFSE peak reveals two phases of recruitment
in the adapted T cells. Both phases, however, decay at
greater rates for the PCC-lo–adapted T cells. Overlay
of dotted lines on each curve represent the fitting of
those parts of the data to a linear regression.T
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B10.A splenocytes (Fig. 4, a and b) or titrations of plate-
bound anti-CD3 and soluble anti-CD28 (Fig. 4, c and d).
Cytokine production from such stimulation assays were
compared with naive 5C.C7 T cells or T cells previously
primed in vivo with a single pulse of PCC plus LPS as de-
scribed in Materials and Methods.
Upon stimulation with APC plus peptide or anti-CD3
plus anti-CD28, T cells resident in either antigen-bearing
host for 20 d or longer consistently showed a dramatic
down-regulation ( 90%) of IL-2 secretion compared with
naive 5C.C7 T cells or primed T cells (Fig. 4 a). Relative
to primed T cells, the adapted cells also down-regulated
IFN-  production by up to 85% (Fig. 4 b). As previously
reported (18), T cells that had expanded in an antigen-free,
lymphopenic environment did not down-regulate cytokine
production and behaved similarly to the primed T cells in
our assays.
A kinetic comparison of the onset of the tolerance pro-
cess in the PCC-hi and PCC-lo recipients revealed inter-
esting differences. Down-regulation of IL-2 production in
the PCC-hi host was completely achieved between days 4
and 5 (Fig. 4 a), whereas in the PCC-lo host it took much
longer (16–20 d for the maximal effect). A similar phenom-
enon was observed for IFN-  (Fig. 4 b). After a day of res-
idence in either host, naive T cells were primed for IFN- 
production upon in vitro restimulation, although this initial
priming was occasionally less efficient in the PCC-lo host.
Residence for a period of 6–7 d in the PCC-hi host de-
pleted 50–90% of the IFN-  production and this loss was
stably maintained for 100 d. In contrast, down-regulation
took between 9–12 d to complete in the PCC-lo host, but
was also maintained beyond 3 mo.
After completion of the down-regulation process in both
environments, however, we could still detect subtle differ-
ences in the maximum cytokine production in vitro be-
tween the two adapted T cells, but only with the anti-CD3
plus anti-CD28 stimulus (Fig. 4, c and d). The differences in
maximal IL-2 (mean difference of 2.08-fold in five experi-
ments; P   0.0006 in a paired two-tailed t test) and IFN- 
(mean difference of 1.9-fold in three experiments; P  
0.01) production between the PCC-lo– and PCC-hi–expe-
rienced T cells was consistent over multiple experiments.
The cytokine down-regulation effect was global and af-
fected IL-4, IL-10, and TNF  (Fig. S1, a, b, and c, available
at http://www.jem.org/cgi/content/full/jem.20030913/
DC1). Therefore, although the PCC-hi– and PCC-lo–
adapted T cells were profoundly desensitized relative to na-
ive or primed T cells, they also displayed subtle gradations
in their in vitro responsiveness relative to each other. These
data confirm the existence of a tuning process that is pro-
portional to the strength of the ambient stimulus.
Quantitative Adaptation of TCR Signaling in the PCC-hi
and PCC-lo Resident T Cells. The differences in anti-
CD3– plus anti-CD28–elicited cytokine production be-
tween T cells adapted to the PCC-lo and PCC-hi environ-
ments suggested that signal transduction downstream of the
TCR might have adjusted differently to the two levels of
antigen presentation. To examine this possibility, we as-
sayed the activation of the Ras-MAPK pathway in the
PCC-lo– and PCC-hi–adapted T cells at the level of ERK
phosphorylation. In the adaptive tolerance phase (day 13 in
Fig. 5 a and day 28 in Fig. 5 b), PCC-hi–adapted T cells
showed a 1.7-fold (Fig. 5 c) or 3.4-fold (Fig. 5 d) reduction
in maximal ERK phosphorylation relative to naive T cells.
In the same time frame, PCC-lo–adapted T cells showed
only a 1.2-fold (Fig. 5 a) or 2.2-fold reduction (Fig. 5 b).
Together with a third experiment, the PCC-hi–adapted
cells showed a 1.3-fold greater mean reduction in maximal
ERK phosphorylation relative to the PCC-lo–adapted T
cells (P    0.004). This differential down-regulation of
Figure 4. Adapted T cells down-regulate cytokine
production with different kinetics and to different
extents. (a and b) Maximal cytokine production after a
48-h APC plus peptide stimulation of 104 purified
T cells recovered from the PCC-hi ( ), PCC-lo
( ), or PCC plus LPS-primed ( ) mice at different
days after transfer reveals a faster down-regulation
of IL-2 (a) and IFN-  (b) production in the PCC-hi
environment. (a) Maximal IL-2 production is ex-
pressed as a percentage of that produced by naive T
cells. (b) IFN-  production is expressed as absolute
production in picograms per milliliter. Data points
in (a) and (b) are averaged over two to five separate
experiments for points shown with error bars. (c and
d) After stable maximal down-regulation, a subtle
difference in the responsiveness of PCC-hi– versus
PCC-lo–adapted T cells can be revealed by stimu-
lation with plate-bound anti-CD3 plus soluble
CD28. Representative production of IL-2 (c) and
IFN-  (d) by T cells recovered 34 d after transfer.
IL-2 production is compared with that by T cells
from a naive 5C.C7,RAG2 /  TCR transgenic
mice ( ).T
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TCR proximal signaling is likely to constitute at least part
of the mechanism for the quantitative adaptation of T cell
responses that we have observed.
A Second Phase of T Cell Activation to Persistent Antigen Stim-
ulation Reveals Cell-intrinsic Differences in Adaptive Tolerance.
The expression of activation markers during the response of
T cells in vivo is a robust measure of single cell responses. In
the presence of persistent antigen, activation of naive adop-
tively transferred T cells can be studied by the expression of
activation markers in two phases: a potent early phase that is
completed by 2–3 d, followed by a more subdued second
phase after 10–14 d (18). We compared the two phases of
activation after adoptive transfer of naive 5C.C7,RAG2 / 
T cells into the PCC-hi and PCC-lo environments (Fig. 6).
All of the recovered T cells in either host up-regulated
CD69 with similar kinetics, reaching a peak expression be-
tween 6–12 h. However, the maximal level of expression
(as indicated by the mean fluorescence intensity [MFI] of
CD69 staining in Fig. 6 b) was about twofold higher in the
PCC-hi host, consistent with a stronger stimulus. CD69 ex-
pression was barely detectable by 3 d of residence in both
hosts. The IL-2 receptor   chain (CD25) was maximally
Figure 5. Biochemical alterations in adapted T cells.
(a and b) TCR signal transduction assayed at the level
of ERK phosphorylation is differentially affected in the
PCC-hi–adapted (P-hi,  ) versus PCC-lo–adapted
(P-lo,  ) cells relative to naive T cells (Nv,  ). T cells
stimulated for various times on anti-CD3–coated plates
and analyzed for phosphorylated ERK (p-ERK). Blots
were stripped and reprobed for total ERK (t-ERK).
(c and d) The percentage of phospho-ERK was quan-
titated using a PhosphorImager. Adapted samples were
recovered 13 (a and c) or 28 d (b and d) after transfer.
Figure 6. In vivo T cell reactivation during the adaptive
tolerance phase reveals cell-intrinsic differences. (a–c) Surface
expression of CD69 on naive 5C.C7,RAG2 /  T cells
transferred into the PCC-hi (  or red lines) or the PCC-lo
(  or blue lines) recipients reveals an early phase of greater
responsiveness in the PCC-hi host, followed by greater
responsiveness in the PCC-lo host during the adaptive
tolerance phase. (a) Percentage of cells expressing CD69
on various days after transfer and (b) the MFI of CD69 on
the positive subset of cells on each day. Green lines represent
naive 5C.C7 T cells. (d) T cells were stained for polymer-
ized intracellular actin with Alexa 546–coupled phalloidin,
ex vivo.T
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up-regulated within 12–24 h in both hosts and was not re-
expressed after the second day (Fig. S2 a, available at http://
www.jem.org/cgi/content/full/jem.20030913/DC1). All
of the transferred T cells up-regulated CD44 by day 3
and remained CD44hi as long as 150 d past transfer (Fig.
S2 b, available at http://www.jem.org/cgi/content/full/
jem.20030913/DC1). Although the levels of TCR on the
transferred T cells were comparable to naive T cells for up
to 40 d, a significant down-regulation of the TCR was
sometimes observed in the PCC-lo host past this time (Fig.
S2 c, available at http://www.jem.org/cgi/content/full/
jem.20030913/DC1). The surface expression of CD5 has
been reported to influence TCR sensitivity (9) in naive T
cells. Although CD5 levels were up-regulated in the adap-
tively tolerant T cells (relative to naive T cells), we did not
observe a consistent difference in the expression of this
marker between the PCC-hi– and PCC-lo–adapted T cells
(Fig. S2 d, available at http://www.jem.org/cgi/content/
full/jem.20030913/DC1).
Surprisingly, during the second phase of CD69 expres-
sion, 10–20% more cells in the PCC-lo host displayed the
marker (Fig. 6 a) with a higher MFI (Fig. 6, b and c). The
higher MFI suggests greater transduction of the TCR signal
by the PCC-lo resident T cells despite the actual ambient
stimulus being lower than in the PCC-hi host. To corrob-
orate this conclusion, we examined an independent activa-
tion marker for in vivo TCR signal transduction. TCR
signals are routed through Vav to polymerize actin and es-
tablish the T cell synapse (26). T cells recovered in the
adaptive phase from PCC-lo recipients showed a 1.46-fold
( / 1.11; n   3; P   0.01) higher level of intracellular
polymerized actin ex vivo than those resident in the PCC-
hi host, as measured by the binding of fluorescent phalloi-
din (Fig. 6 d). These F-actin levels were uniformly up-reg-
ulated in all of the PCC-lo–adapted T cells. Thus, although
the first phase of naive T cell activation was greater in the
PCC-hi host, at later times PCC-lo resident T cells evi-
dence greater responsiveness to the ambient stimulation. In
conjugation with our previous demonstration of reversibil-
ity of this adaptively tolerant state (18), these data strongly
argue that the tuning process is cell intrinsic.
Discussion
The TAT model is a theoretical framework for the pre-
diction of how mature peripheral T cells might dynami-
cally adapt their responsiveness in vivo. Naive T cells are
postulated to exist in a tuned state, i.e., in equilibrium
with the level of self-MHC–peptide complexes, and can
proliferate only if the ambient stimulus rapidly exceeds
that of the steady state. Consistent with this assumption,
our transfer of naive T cells from a PCC-free environment
to one expressing PCC elicits a proliferative burst. During
the initial phases of this response, the antigen presentation
environment in the host undergoes subtle alterations (un-
published data) but returns to its original steady state
within 4–5 d as measured by the ability of a labeled second
cohort of naive T cells to proliferate in this environment
(18). In this new steady state of persistent antigen presenta-
tion, the original T cells enter a form of hyporesponsive-
ness that appears to last from several weeks to months.
Upon removal from this steady state and transfer into an
antigen-free, T cell–deficient host, the T cells gradually
recover their responsiveness (18). The TAT model would
suggest that this reversible hyporesponsiveness results from
a tunability of TCR activation thresholds, dictated by the
extent of persistent stimulation available in the environ-
ment. Accordingly, a fourfold difference in persistent anti-
gen presentation should also result in different adaptive
states in the transferred T cells. Such a difference was ob-
served in a comparison of the ability of the recovered T
cells to proliferate in vivo as well as to signal and produce
cytokines upon direct stimulation of the TCR complex in
vitro. Sustained exposure to an environment expressing
more antigen-specific APC function (PCC-hi) resulted in
greater refractoriness to T cell reactivation. Therefore, this
basic set of observations is compatible with the original
predictions of the TAT model.
One clear functional consequence of the adaptive pro-
cess in this system is to adjust the in vivo turnover of T
cells to similar levels (Fig. 2 d) despite a fourfold differ-
ence in stimulation strengths. Proliferation is an endpoint
of a cellular calculus integrating the strength and duration
of TCR occupancy and costimulatory signaling at the nu-
clear level (27). Therefore, the effective proliferative sig-
nal perceived by T cells, showing the same turnover in
the high and low stimulus environments, must be similar.
Because the actual antigen presentation in the two mice
are different, the integrated signal can only be equivalent
if one or more of the TCR signaling cascades are more
strongly inhibited in the PCC-hi host. We have shown
that this is indeed true in one pathway: that of Ras-
MAPK at the level of ERK phosphorylation. The actual
nature of the “tuning machinery” might involve the re-
cruitment of proportional negative feedback into multiple
pathways downstream of the TCR (28 and unpublished
data). Yet, the adaptive states in the two hosts display
some differences that are inconsistent with a simple linear
compensation of signal strength by negative feedback.
The initial expansion of naive T cells in the two hosts sta-
bilizes at two- to fourfold different numbers in the adap-
tive phase. Negative feedback that is elicited in linear cor-
respondence to the strength of stimulus might have been
expected to enforce a greater slowdown in the PCC-hi
environment relative to the PCC-lo environment, effec-
tively achieving similar plateau levels in the two hosts. In
our system, however, the stopping of expansion actually
precedes the achievement of complete tolerance (at least
in the PCC-lo environment) as measured by cytokine
down-regulation and in vivo proliferation. It is therefore
arguable that the adaptive tolerance measured at the steady
state is regulated independently of the mechanisms that
restrict the initial proliferative burst of T cells. Such a bi-
furcation essentially restricts application of the TAT
model to the time frame of the post-expansion adaptive
tolerance phase in our system.T
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Two other complexities that are challenging for the
TAT model are that PCC-lo–adapted T cells display
nearly twice as much CD69 and 1.4-fold higher polymer-
ized actin in vivo compared with the PCC-hi–adapted
cells. These observations suggest that in the post-adaptive
scenario greater amounts of TCR signals are being trans-
duced by the PCC-lo–adapted T cells in response to the
ambient PCC-lo stimulus itself, relative to transduction by
the PCC-hi–adapted T cells of the PCC-hi stimulus in
vivo. Such an over (in PCC-hi) and/or under (in PCC-
lo) compensation is not predicted by a model that envi-
sions direct balancing of antigen presentation strength by
negative feedback operating on TCR proximal signaling
events. Adaptation therefore seems to be primarily con-
cerned with restricting the proliferative potential of T
cells after an initial wave of response in the context of per-
sistence of stimulus. Because multiple pathways down-
stream of the TCR contribute differentially to entry into
cell cycle, different extents of negative feedback may need
to be initiated in different pathways to effectively control
the cell cycle. Persistent signaling could continue to re-
cruit more inhibition into the active transduction path-
ways of the anergic T cells, until the integrated nuclear
signal is only sufficient to allow a basal turnover, which is
interestingly also observed for memory T cells in vivo
(29). In the case of the weaker stimulus environment
there would be less inhibition required to reduce the
turnover, leading to less complete inhibition of some of
the signaling pathways. This could allow for TCR signal-
ing to continue triggering consequences that are elicited at
a lower threshold of signaling in those pathways alone.
For example, an incomplete block of the MAPK pathway
or of the JNK pathway might allow for the expression of
CD69 or apoptotic processes, respectively, in the PCC-lo
environment, even after turnover has been constrained.
This could explain the slow but significant loss of T cells
( 50%) in the PCC-lo host after 3–4 mo. Furthermore,
because the expression of negative feedback is also likely
to depend on the strength of the signal (30), T cells in the
lower stimulus environment might also take longer to re-
cruit adequate feedback to reach the adaptive state. This is
consistent with the delay for entry into tolerance observed
in the PCC-lo host as measured by the kinetics of IL-2
and IFN-  down-regulation.
A critical deficiency in the literature pertaining to the
tunability of T cell activation thresholds is the inability of
many experimental systems to distinguish selection for ex-
isting variability in the population from tuning of an indi-
vidual cell’s threshold. This is largely because of the use of
polyclonal populations or TCR transgenic cells with en-
dogenously rearranged receptors, which impart variable
properties to the starting population that can then be se-
lected upon. In contrast, our original T cell cohort is de-
rived from a RAG2-null TCR transgenic mouse in which
 95% of cells are CD69 , CD25 , and CD44lo and express
similar levels of TCR. Commensurate with this homoge-
neity, the cells also behave as a fairly synchronous popula-
tion during in vivo proliferation in the PCC-hi host (initial
divisions follow a Gaussian distribution with a SD   1).
Furthermore, after adaptation has been established, phalloi-
din staining shows a homogeneous population of differen-
tially responsive T cells in the two environments. There-
fore, our observations are most likely documenting the
adaptive changes acquired at the level of individual cells
from a homogeneous pot of naive T cells.
Nonetheless, as a theoretical alternative to the TAT
model to explain our results, it is still possible to envision
complex processes of selection operating on subtle intrinsic
differences in the monoclonal naive T cell population stim-
ulated at less than optimal conditions. A selection hypothe-
sis that assumes heritable differences in our starting popula-
tion of TCR transgenic T cells is unlikely to explain our
observations because the hyporesponsiveness is reversible in
the absence of antigen (18). A more complex model of se-
lection, however, could assume that individual T cells con-
stitutively oscillate in their responsiveness over an indeter-
minate range. Such a model would explain our results by
arguing that cells that are sufficiently responsive at any
given instant to be activated by the ambient stimulus would
be depleted by deletion or migration. The lymphoid com-
partment would thus only maintain cohorts of T cells that
display responsiveness oscillations lower than that stimu-
latable by the presented antigen. Hence, two different am-
bient stimuli would produce two populations with different
mean responsiveness. Such an “oscillating responsiveness”
scenario shares an attractive feature of the TAT model in
that it predicts T cell responsiveness to be a dynamic and
variable property rather than a binary gate. In contrast to
the TAT model, however, it does not subsequently as-
cribe tunability to the intrinsic TCR thresholds. Although
the two models invoke different mechanisms (selection
vs. tuning), the endpoint in either case is the same, i.e.,
the availability of a dynamic range of T cell responsive-
ness that can effectively be adapted to a given persistent
stimulus.
Because the oscillating responsiveness model does not al-
low for cell-intrinsic tuning, it would predict that T cell re-
sponses should be proportional to the ambient stimulus,
i.e., cells in the PCC-hi environment should always make
equal or greater responses than those in the PCC-lo envi-
ronment. Our observations of both a lower MFI of CD69
and a lower level of actin polymerization in the PCC-hi–
adapted T cells is contrary to such a prediction. This dis-
crepancy is thus a strong argument for the existence of cell-
intrinsic tunability as envisioned by the TAT model. Still,
the complexity of the cell-intrinsic adaptive behavior that
we have observed calls for further refinement of the theo-
retical models to better define the molecular networks
driving TATs in peripheral CD4  T cells.
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